Overview
Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research.
Dr. Yarchoan is rated as an Experienced provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy.
His clinical research consists of co-authoring 139 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Thyroid Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Viragh BLDG 5th FL, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
University Of Maryland Oncology Associates PA
Taofeek Owonikoko is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Owonikoko is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Owonikoko is currently accepting new patients.
Ann Gramza is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Gramza is rated as a Distinguished provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Anaplastic Thyroid Cancer, Thyroid Cancer, Medullary Thyroid Carcinoma, and Laryngeal Cancer.
University Of Maryland Oncology Associates PA
Kevin Cullen is an Oncologist in Baltimore, Maryland. Dr. Cullen is rated as a Distinguished provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Olfactory Neuroblastoma, Teratocarcinosarcoma, and Laryngeal Cancer. Dr. Cullen is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Cholangiocarcinoma (Bile Duct Cancer)
- Fibrolamellar CarcinomaDr. Yarchoan isElite. Learn about Fibrolamellar Carcinoma.
- Distinguished
- Liver CancerDr. Yarchoan isDistinguished. Learn about Liver Cancer.
- Advanced
- Pancreatic CancerDr. Yarchoan isAdvanced. Learn about Pancreatic Cancer.
- Experienced
- Colorectal CancerDr. Yarchoan isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Yarchoan isExperienced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Yarchoan isExperienced. Learn about Familial Pancreatic Cancer.
- Gallbladder AdenocarcinomaDr. Yarchoan isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Yarchoan isExperienced. Learn about Gallbladder Cancer.
- Head and Neck Squamous Cell Carcinoma (HNSCC)